Funding Round Overview

Update
Founded:
1998
Headquarters:
Eagan, MN
Funding:
$4.30M
Categories:
Automotive

Cardiais an innovative company engaged in developing, manufacturing and marketing transcatheter septal occluders.

Description

Update

Incorporated in 1998, Cardia, Inc. is an innovative company engaged in developing, manufacturing and marketing transcatheter septal occluders. To date we have closed over 15,000 septal defects worldwide.

Ultrasept, our latest family of products, serves as our 7th generation of septal closure devices. The dual articulating sails allow for easy deployment of the devices and create a super low profile within the atria. Ultrasept devices boast a simple, hands-free loading feature and are fully retrievable before and after release. Ultrasept products include double-round devices for the percutaneous closure of both PFO’s (Patent Foramen Ovale) and ASD’s (Atrial Septal Defect).

A septal occluder is a cardiac implant that fixes a cardiac defect commonly referred to as a “hole in the heart." Our devices are delivered through a catheter by an interventional cardiologist and only take about 30 minutes to implant. Many... See More

Funding Rounds (4) - $4.30M

Update
  • $550k

    Investors Unknown
    Jun 27, 2013 -Unknown
  • $400k

    Investors Unknown
    May 7, 2013 -Unknown
  • $1.20M

    Investors Unknown
    Oct 31, 2012 -Unknown
  • $2.10M

    Investors Unknown
    Jul 29, 2011 -Unknown

Offices/Locations (1)

Update
  • Office

    2900 Lone Oak Parkway

    Suite 130

    Eagan, MN 55121

    USA

Images (1)

Update
  • 739ef924efe1cf56c6ac82aea7d77d40